Alpha2-macroglobulin and eosinophil cationic protein in the allergic airway mucosa in seasonal allergic rhinitis
- PMID: 10232439
- DOI: 10.1183/09031936.99.13363399
Alpha2-macroglobulin and eosinophil cationic protein in the allergic airway mucosa in seasonal allergic rhinitis
Abstract
As previously demonstrated in seasonal allergic rhinitis, increased microvascular permeability and eosinophil activation are key features of allergic airway inflammation. In the present study, the hypothesis that exudation of alpha2-macroglobulin may cause the appearance of eosinophil cationic protein (ECP) in the airway lumen was explored. Nasal lavages were carried out using the nasal pool device before and during the pollen season both at baseline and after histamine challenge in 10 children with allergic rhinitis. Nasal lavage fluid levels of alpha2-macroglobulin and ECP were determined. All patients experienced nasal symptoms of allergic rhinitis during the pollen season (p<0.01-0.05). Baseline nasal lavage fluid levels of alpha2-macroglobulin and ECP were increased during the season (p<0.01-0.05) and were found to be well correlated (p<0.0001). Histamine produced concentration-dependent plasma exudation before and during the pollen season, but it was only during the pollen season that this caused an increase in the lavage fluid levels of ECP (p<0.05). These data suggest that exudation of plasma and increased tissue levels and output of eosinophil cationic protein characterize nasal mucosal inflammation in children with seasonal allergic rhinitis. The plasma exudation process in part may account for lumenal entry of eosinophil cationic protein molecules that have been released in mucosal tissue compartments. A combination of induced exudation and nasal lavage may improve the yield of important markers of inflammation in studies of nasal diseases.
Similar articles
-
Steroid-sensitive indices of airway inflammation in children with seasonal allergic rhinitis.Pediatr Allergy Immunol. 2003 Feb;14(1):60-5. doi: 10.1034/j.1399-3038.2003.02102.x. Pediatr Allergy Immunol. 2003. PMID: 12603713 Clinical Trial.
-
Eosinophil degranulation status in allergic rhinitis: observations before and during seasonal allergen exposure.Eur Respir J. 2004 Nov;24(5):750-7. doi: 10.1183/09031936.04.00133603. Eur Respir J. 2004. PMID: 15516668
-
Demonstration of bronchial eosinophil activity in seasonal allergic rhinitis by induced plasma exudation combined with induced sputum.Thorax. 1999 Jan;54(1):33-6. doi: 10.1136/thx.54.1.33. Thorax. 1999. PMID: 10343628 Free PMC article.
-
Nasal mucosal endorgan hyperresponsiveness.Am J Rhinol. 1998 Jan-Feb;12(1):37-43. doi: 10.2500/105065898782103016. Am J Rhinol. 1998. PMID: 9513658 Review.
-
Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease.Clin Exp Allergy. 1999 Sep;29(9):1172-86. doi: 10.1046/j.1365-2222.1999.00542.x. Clin Exp Allergy. 1999. PMID: 10469025 Review. No abstract available.
Cited by
-
Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease.J Allergy Clin Immunol. 2015 Sep;136(3):737-746.e4. doi: 10.1016/j.jaci.2015.01.043. Epub 2015 Apr 1. J Allergy Clin Immunol. 2015. PMID: 25840724 Free PMC article.
-
Allergen provocation tests in respiratory research: building on 50 years of experience.Eur Respir J. 2022 Aug 25;60(2):2102782. doi: 10.1183/13993003.02782-2021. Print 2022 Aug. Eur Respir J. 2022. PMID: 35086834 Free PMC article. Review.
-
A two-year course of specific immunotherapy or of continuous antihistamine treatment reverse eosinophilic inflammation in severe persistent allergic rhinitis.Acta Otorhinolaryngol Ital. 2005 Oct;25(5):284-91. Acta Otorhinolaryngol Ital. 2005. PMID: 16602327 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials